These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 16009814)

  • 1. Combined PET-CT in the head and neck: part 1. Physiologic, altered physiologic, and artifactual FDG uptake.
    Blodgett TM; Fukui MB; Snyderman CH; Branstetter BF; McCook BM; Townsend DW; Meltzer CC
    Radiographics; 2005; 25(4):897-912. PubMed ID: 16009814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined PET-CT in the head and neck: part 2. Diagnostic uses and pitfalls of oncologic imaging.
    Fukui MB; Blodgett TM; Snyderman CH; Johnson JJ; Myers EN; Townsend DW; Meltzer CC
    Radiographics; 2005; 25(4):913-30. PubMed ID: 16009815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pediatric FDG PET/CT: physiologic uptake, normal variants, and benign conditions.
    Shammas A; Lim R; Charron M
    Radiographics; 2009; 29(5):1467-86. PubMed ID: 19755606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Head and neck: normal variations and benign findings in FDG positron emission tomography/computed tomography imaging.
    Højgaard L; Berthelsen AK; Loft A
    PET Clin; 2014 Apr; 9(2):141-5. PubMed ID: 25030278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PET-CT fusion imaging in differentiating physiologic from pathologic FDG uptake.
    Kostakoglu L; Hardoff R; Mirtcheva R; Goldsmith SJ
    Radiographics; 2004; 24(5):1411-31. PubMed ID: 15371617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Present and future role of FDG-PET/CT imaging in the management of head and neck carcinoma.
    Kitajima K; Suenaga Y; Sugimura K
    Jpn J Radiol; 2015 Dec; 33(12):776-89. PubMed ID: 26507982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Normal FDG distribution patterns in the head and neck: PET/CT evaluation.
    Nakamoto Y; Tatsumi M; Hammoud D; Cohade C; Osman MM; Wahl RL
    Radiology; 2005 Mar; 234(3):879-85. PubMed ID: 15734938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coregistration of FDG PET and MRI of the head and neck using normal distribution of FDG.
    Uematsu H; Sadato N; Yonekura Y; Tsuchida T; Nakamura S; Sugimoto K; Waki A; Yamamoto K; Hayashi N; Ishii Y
    J Nucl Med; 1998 Dec; 39(12):2121-7. PubMed ID: 9867154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of combined (18)F-FDG PET/CT in head and neck tumours.
    Syed R; Bomanji JB; Nagabhushan N; Hughes S; Kayani I; Groves A; Gacinovic S; Hydes N; Visvikis D; Copland C; Ell PJ
    Br J Cancer; 2005 Mar; 92(6):1046-50. PubMed ID: 15770212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perineural spread in head and neck malignancies: clinical significance and evaluation with 18F-FDG PET/CT.
    Paes FM; Singer AD; Checkver AN; Palmquist RA; De La Vega G; Sidani C
    Radiographics; 2013 Oct; 33(6):1717-36. PubMed ID: 24108559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 18F-FDG imaging: pitfalls and artifacts.
    Abouzied MM; Crawford ES; Nabi HA
    J Nucl Med Technol; 2005 Sep; 33(3):145-55; quiz 162-3. PubMed ID: 16145222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FDG PET/CT interobserver agreement in head and neck cancer: FDG and CT measurements of the primary tumor site.
    Jackson T; Chung MK; Mercier G; Ozonoff A; Subramaniam RM
    Nucl Med Commun; 2012 Mar; 33(3):305-12. PubMed ID: 22227560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Head and neck cancers: post-therapy changes in muscles with FDG PET-CT.
    Matthews R; Shrestha P; Franceschi D; Relan N; Kaloudis E
    Clin Nucl Med; 2010 Jul; 35(7):494-8. PubMed ID: 20548140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atypical
    Childs L; Thompson A; Jones H; Hameeduddin A; Ghufoor K; Adams A
    Clin Imaging; 2018; 49():136-143. PubMed ID: 29414508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Special Techniques in PET/Computed Tomography Imaging for Evaluation of Head and Neck Cancer.
    Kumar R; Mukherjee A; Mittal BR
    PET Clin; 2016 Jan; 11(1):13-20. PubMed ID: 26590440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can 3'-Deoxy-3'-((18)F) Fluorothymidine Out Perform 2-Deoxy-2-((18)F) Fluoro-D-Glucose Positron Emission Tomography/Computed Tomography in the Diagnosis of Cervical Lymphadenopathy in Patients With Oral/Head and Neck Cancer?
    Schaefferkoetter JD; Carlson ER; Heidel RE
    J Oral Maxillofac Surg; 2015 Jul; 73(7):1420-8. PubMed ID: 25869746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utility of 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography and positron emission tomography/computed tomography imaging in the preoperative staging of head and neck squamous cell carcinoma.
    Roh JL; Yeo NK; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
    Oral Oncol; 2007 Oct; 43(9):887-93. PubMed ID: 17207656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bowel hot spots at PET-CT.
    Prabhakar HB; Sahani DV; Fischman AJ; Mueller PR; Blake MA
    Radiographics; 2007; 27(1):145-59. PubMed ID: 17235004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual modality of 18F-fluorodeoxyglucose-positron emission tomography/computed tomography in patients with cervical carcinoma of unknown primary.
    Freudenberg LS; Fischer M; Antoch G; Jentzen W; Gutzeit A; Rosenbaum SJ; Bockisch A; Egelhof T
    Med Princ Pract; 2005; 14(3):155-60. PubMed ID: 15863988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The value of PET-CT imaging in malignant tumours of the head and neck].
    Balink H; Krabbe CA; de Visscher JG
    Ned Tijdschr Geneeskd; 2007 May; 151(21):1167-72. PubMed ID: 17557755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.